Class information for:
Level 1: SISCAPA//PSAQ//BIOMARKER VERIFICATION

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
15959 614 37.7 86%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
356 16803 PROTEOMICS//JOURNAL OF PROTEOME RESEARCH//PROTEIN IDENTIFICATION

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 SISCAPA Author keyword 9 64% 1% 9
2 PSAQ Author keyword 9 83% 1% 5
3 BIOMARKER VERIFICATION Author keyword 9 67% 1% 8
4 MULTIPLE REACTION MONITORING Author keyword 7 16% 6% 39
5 GENOME BRITISH COLUMBIA PROTE Address 7 33% 3% 17
6 OFF CANC CLIN PROTE Address 4 47% 1% 7
7 SELECTED REACTION MONITORING Author keyword 4 14% 5% 28
8 TARGETED PROTEOMICS Author keyword 4 16% 3% 21
9 MRM Author keyword 4 13% 4% 26
10 GENOME BC PROTE Address 3 20% 2% 11

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 SISCAPA 9 64% 1% 9 Search SISCAPA Search SISCAPA
2 PSAQ 9 83% 1% 5 Search PSAQ Search PSAQ
3 BIOMARKER VERIFICATION 9 67% 1% 8 Search BIOMARKER+VERIFICATION Search BIOMARKER+VERIFICATION
4 MULTIPLE REACTION MONITORING 7 16% 6% 39 Search MULTIPLE+REACTION+MONITORING Search MULTIPLE+REACTION+MONITORING
5 SELECTED REACTION MONITORING 4 14% 5% 28 Search SELECTED+REACTION+MONITORING Search SELECTED+REACTION+MONITORING
6 TARGETED PROTEOMICS 4 16% 3% 21 Search TARGETED+PROTEOMICS Search TARGETED+PROTEOMICS
7 MRM 4 13% 4% 26 Search MRM Search MRM
8 ANTIBODY ENRICHMENT 2 67% 0% 2 Search ANTIBODY+ENRICHMENT Search ANTIBODY+ENRICHMENT
9 MULTIPLEXED QUANTITATION 2 67% 0% 2 Search MULTIPLEXED+QUANTITATION Search MULTIPLEXED+QUANTITATION
10 ABSOLUTE QUANTIFICATION 2 11% 3% 19 Search ABSOLUTE+QUANTIFICATION Search ABSOLUTE+QUANTIFICATION

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PEPTIDE IMMUNOAFFINITY ENRICHMENT 44 74% 5% 32
2 MULTIPLEXED ASSAYS 26 69% 4% 22
3 ABSOLUTE QUANTIFICATION 24 17% 20% 125
4 PELLET DIGESTION 23 100% 2% 10
5 TARGETED MASS SPECTROMETRY 13 47% 3% 21
6 MASS SPECTROMETRIC IMMUNOASSAY 11 45% 3% 19
7 PEPTIDE ENRICHMENT 8 75% 1% 6
8 SEQUENTIAL PROTEIN 8 75% 1% 6
9 ORTHOGONAL ARRAY OPTIMIZATION 7 67% 1% 6
10 PEPTIDE STANDARDS 6 48% 2% 10

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Clinical protein mass spectrometry 2015 3 68 40%
Bioanalytical LC-MS/MS of protein-based biopharmaceuticals 2013 38 167 54%
Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS 2011 63 62 42%
Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry 2012 30 44 57%
Application and challenges in using LC- MS assays for absolute quantitative ana- lysis of therapeutic proteins in drug discovery 2014 6 94 61%
Quantitation of human peptides and proteins via MS: review of analytically validated assays 2014 7 102 53%
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum 2010 139 13 31%
Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays 2014 9 103 44%
Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS 2012 30 53 53%
Analytical Validation of Protein-Based Multiplex Assays: A Workshop Report by the NCI-FDA Interagency Oncology Task Force on Molecular Diagnostics 2010 23 2 100%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 GENOME BRITISH COLUMBIA PROTE 7 33% 2.8% 17
2 OFF CANC CLIN PROTE 4 47% 1.1% 7
3 GENOME BC PROTE 3 20% 1.8% 11
4 BIOANAL US 2 67% 0.3% 2
5 GLOBAL DMPK BIOANALYT RD 2 67% 0.3% 2
6 STRELETZ DIABET 2 67% 0.3% 2
7 EARLY DEV SERV 2 33% 0.7% 4
8 STRATEG SCI INITIAT 2 23% 1.0% 6
9 BIOANALYT SCI ANALYT BIOANALYT DEV 1 50% 0.3% 2
10 BIOANALYT SCI DEV 1 50% 0.3% 2

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000218404 PEPTIDE IDENTIFICATION//JOURNAL OF PROTEOME RESEARCH//QUANTITATIVE PROTEOMICS
2 0.0000155385 SELDI//SELDI TOF MS//LOW ABUNDANCE PROTEOME
3 0.0000144056 AFFINITY MASS SPECTROMETRY//PEPTIDE CHIP ANALYSIS//PROTEOLYTIC EPITOPE EXCISION
4 0.0000110814 BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES
5 0.0000108779 BIOANALYSIS//BIOANALYT METAB PHARMACOKINET//CASSETTE ANALYSIS
6 0.0000105403 GPLLI PROGRAM//IMMOBILIZED TRYPSIN//PROTEIN DIGESTION
7 0.0000095757 PROTEIN ATLAS//PREST//HUMAN PROTEIN ATLAS
8 0.0000081420 AMNIOTIC FLUID SUPERNATANT//CERVICAL VAGINAL FLUID//UNITE MED MATERNO FOETALE
9 0.0000074426 URINARY PROTEOMICS//URINARY PROTEOME//URINE PROTEOME
10 0.0000064521 CIBER BBN SALUD CARLOS 3//RIER RED INFLAMAC ENFERMEDADES REUMAT//PROTEORED ISCIII PROTE GRP